Butterfly Network vs Sanara MedTech
Sanara MedTech reported revenue of $103 million in fiscal 2025, about the same as Butterfly Network's $98 million in fiscal 2025. Butterfly Network's revenue grew 19.0% in its latest year, and Sanara MedTech's grew 19.0%. Butterfly Network had an operating margin of -88.5%, against 7.1% at Sanara MedTech. Free cash flow was −$16 million at Butterfly Network and $2 million at Sanara MedTech.
Side by side
| Butterfly Network | Sanara MedTech | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $98M | $103M |
| Revenue growth | 19.0% | 19.0% |
| Revenue growth a year, last 5 years | 16.1% | 45.9% |
| Gross margin | 46.9% | 92.7% |
| Operating margin | −88.5% | 7.1% |
| Net margin | −79.0% | −36.4% |
| Free cash flow | −$16M | $2M |
| Free cash flow margin | −16.4% | 2.1% |
| Return on capital | — | 13.0% |
| Net debt to EBITDA | — | 2.6x |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 16.7% | 1.6% |
| Last close | $5.85 | $32.67 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $10.7 million, sold $127.7 million | — |
| Piotroski F-score | — | 3 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Butterfly NetworkSanara MedTech
Operating margin
Percent of revenue
Butterfly NetworkSanara MedTech
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Butterfly NetworkSanara MedTech
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Butterfly Network and Sanara MedTech pages.